Sandu Pharmaceuticals P/E Ratio

Current P/E Ratio
22.48
Moderate Valuation
High - Growth expectations or overvalued

Sandu Pharmaceuticals P/E ratio. Sandu Pharmaceuticals (SANDUPHQ) P/E ratio is 22.48 (Moderate), EPS (TTM) ₹1.60, current price ₹37.27 on BSE vs historical average P/E of 38.78 (33.3th percentile) — High - Growth expectations or overvalued. For live price, revenue and the complete fundamental profile, see Sandu Pharmaceuticals share price today.

Current Valuation Metrics

P/E Ratio 22.48
Current Price ₹37.27
EPS (TTM) ₹1.60
Exchange BSE

Valuation Signal

Signal Overvalued
Historical Avg 38.78
Historical Range 17.3 - 59.22
Percentile 33.3%

Sector Context

Sector Average 56.36
Sector Median 32.5
Sector Rank #11 of 199
Sector Percentile 5.5%

Earnings Breakdown (TTM)

TTM EPS ₹3.08
Mar 2025 ₹0.34
Sept 2024 ₹1.95

SANDUPHQ P/E Ratio — Valuation Signal & Historical Context

Sandu Pharmaceuticals P/E 22.48 vs historical average 38.78, range 17.3–59.22 — signal: Overvalued. Also explore Sandu Pharmaceuticals share price performance to track price trends across different timeframes.

  • Current PE is 42.0% below historical average
  • Trading at discount to sector average PE of 56.36

Sandu Pharmaceuticals P/E Ratio Historical Trend

SANDUPHQ annual price-to-earnings ratio — 3 years, EPS and year-end price. Current P/E 22.48 vs historical average 38.78. Examine SANDUPHQ quarterly trends for recent quarterly revenue, profit and EPS trends.

SANDUPHQ Historical P/E Ratio — EPS, Year-End Price & Valuation

Sandu Pharmaceuticals annual P/E ratio, EPS (₹), year-end price and valuation category on BSE.

Year P/E Ratio EPS (₹) Year-end Price (₹) Exchange Valuation
2024 17.3 3.31 ₹57.26 BSE Moderate
2023 59.22 1.15 ₹68.10 BSE High
2022 39.82 1.68 ₹66.90 BSE High

SANDUPHQ vs Healthcare Peers — P/E Ratio Comparison

Sandu Pharmaceuticals P/E 22.48 vs Healthcare average 56.36, median 32.5 — range 2.04–740.29.

Sector Average
56.36
Sector Median
32.5
Lowest P/E
2.04
Highest P/E
740.29
Companies
199
Company Symbol P/E Ratio Market Cap (₹ Cr) Valuation
Sunrest Lifescience SUNREST 2.04 ₹65 Low
Murae Organisor MURAE 2.86 ₹41 Low
Phaarmasia PHRMASI 3.41 ₹63 Low
Sun Pharma Advanced Rese… SPARC 3.98 ₹6,206 Low
Dipna Pharmachem DPL 4.57 ₹12 Low
JFL Life Sciences JFLLIFE 4.88 ₹66 Low
GKB Ophthalmics GKB 5.88 ₹32 Low
Kabra Drugs KABRADG 6.09 ₹44 Low
Royal Sense ROYAL 6.58 ₹47 Low
Colinz Laboratories COLINZ 6.62 ₹18 Low